Assured Investment Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
– Sell
-62,198
Closed -$2.2M – 1140
2018
Q4
$2.2M Buy
+62,198
New +$2.26M 0.06% 329
2018
Q3
– Sell
-162,079
Closed -$5.3M – 1167
2018
Q2
$5.3M Sell
162,079
-53,422
-25% -$1.61M 0.1% 223
2018
Q1
$5.89M Buy
215,501
+105,271
+96% +$2.86M 0.13% 193
2017
Q4
$2.73M Buy
+110,230
New +$3.04M 0.06% 327
2017
Q3
– Sell
-30,060
Closed -$833K – 605
2017
Q2
$833K Sell
30,060
-61,282
-67% -$1.63M 0.02% 422
2017
Q1
$2.27M Buy
91,342
+43,118
+89% +$1.05M 0.05% 155
2016
Q4
$1.04M Sell
48,224
-60,991
-56% -$1.33M 0.02% 309
2016
Q3
$2.6M Buy
109,215
+66,907
+158% +$1.6M 0.06% 145
2016
Q2
$989K Buy
+42,308
New +$915K 0.02% 279
2015
Q2
– Sell
-34,763
Closed -$617K – 651
2015
Q1
$617K Buy
+34,763
New +$549K 0.01% 215

Other funds holding BSX

Assured Investment Management's BSX Position: Q1 2019 in Review

Assured Investment Management sold out of Boston Scientific (BSX) in Q1 2019, closing a stake of 62,198 shares — an estimated $2.2M sold.

Assured Investment Management first reported a position in BSX in Q1 2015 and held it in 10 quarters. The position peaked at $5.89M in Q1 2018. 789 funds tracked by Wall St. Rank hold BSX as of Q1 2019.

  • Assured Investment Management reported no remaining Boston Scientific position as of Q1 2019 after selling out during the quarter.
  • Assured Investment Management sold 62,198 Boston Scientific shares in Q1 2019, an estimated $2.2M.
  • Assured Investment Management first reported a position in Boston Scientific in Q1 2015 and held it in 10 quarters.
  • Assured Investment Management's Boston Scientific position peaked at $5.89M in Q1 2018.
  • 789 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2019.

Based on Assured Investment Management's 13F filing for Q1 2019, filed 16 May 2019.